Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Retinoblastoma: lessons and challenges from developing countries. Ellsworth Lecture 2011.

Chantada GL.

Ophthalmic Genet. 2011 Nov;32(4):196-203. doi: 10.3109/13816810.2011.592173. Epub 2011 Jul 19. Review.

PMID:
21770696
2.

Strategies to manage retinoblastoma in developing countries.

Chantada GL, Qaddoumi I, Canturk S, Khetan V, Ma Z, Kimani K, Yeniad B, Sultan I, Sitorus RS, Tacyildiz N, Abramson DH.

Pediatr Blood Cancer. 2011 Mar;56(3):341-8. doi: 10.1002/pbc.22843. Epub 2010 Nov 11. Review.

PMID:
21225909
3.

Clinical presentation of retinoblastoma in a middle-income country.

Navo E, Teplisky D, Albero R, Fandino AC, Demirdjian G, Chantada GL.

J Pediatr Hematol Oncol. 2012 Apr;34(3):e97-101. doi: 10.1097/MPH.0b013e31821d18f9.

PMID:
22009008
4.

The effect of therapy refusal against medical advice in retinoblastoma patients in a setting where treatment delays are common.

Sitorus RS, Moll AC, Suhardjono S, Simangunsong LS, Riono P, Imhof S, Völker-Dieben HJ.

Ophthalmic Genet. 2009 Mar;30(1):31-6. doi: 10.1080/13816810802464320.

PMID:
19172508
5.

Histological determinant of mortality in retinoblastoma in Ibadan.

Ajaiyeoba IA, Komolafe OO, Olusanya BA, Akang EE.

Br J Ophthalmol. 2008 Sep;92(9):1297-8. doi: 10.1136/bjo.2008.139501. No abstract available.

PMID:
18723749
6.

Secondary neoplasms after retinoblastoma treatment: retrospective cohort study of 754 patients in Japan.

Araki Y, Matsuyama Y, Kobayashi Y, Toyokawa S, Inoue K, Suzuki S, Makimoto A.

Jpn J Clin Oncol. 2011 Mar;41(3):373-9. doi: 10.1093/jjco/hyq201. Epub 2010 Nov 4.

PMID:
21051531
7.

Clinical and epidemiological characteristics of retinoblastoma: correlation with prognosis in a Turkish pediatric oncology center.

Ozdemir H, Tacyildiz N, Unal E, Yavuz G, Ugur H, Gunduz K.

Pediatr Hematol Oncol. 2007 Apr-May;24(3):221-31.

PMID:
17454793
8.

Retinoblastoma in Taiwan: survival and clinical characteristics 1978-2000.

Kao LY, Su WW, Lin YW.

Jpn J Ophthalmol. 2002 Sep-Oct;46(5):577-80.

PMID:
12457919
9.

Survival of retinoblastoma in less-developed countries impact of socioeconomic and health-related indicators.

Canturk S, Qaddoumi I, Khetan V, Ma Z, Furmanchuk A, Antoneli CB, Sultan I, Kebudi R, Sharma T, Rodriguez-Galindo C, Abramson DH, Chantada GL.

Br J Ophthalmol. 2010 Nov;94(11):1432-6. doi: 10.1136/bjo.2009.168062. Epub 2010 Aug 23. Review.

PMID:
20733021
10.

Prognosis in retinoblastoma: influence of histopathologic characteristics.

Kobrin JL, Blodi FC.

J Pediatr Ophthalmol Strabismus. 1978 Sep-Oct;15(5):278-81. doi: 10.3928/0191-3913-19780901-04.

PMID:
24877465
11.

Clinical pathologic study of a cohort of patients with retinoblastoma from a developing country.

Orellana ME, Fernandes BF, Arean C, Pifano I, Al-Kandari A, Burnier MN Jr.

J Pediatr Ophthalmol Strabismus. 2009 Sep-Oct;46(5):294-9. doi: 10.3928/01913913-20090903-07. Epub 2009 Sep 22.

PMID:
19791727
12.

Outcome of patients with retinoblastoma and postlaminar optic nerve invasion.

Chantada GL, Casco F, Fandiño AC, Galli S, Manzitti J, Scopinaro M, Schvartzman E, de Dávila MT.

Ophthalmology. 2007 Nov;114(11):2083-9. Epub 2007 Apr 24.

PMID:
17459482
13.

Retinoblastoma in Iran: outcomes in terms of patients' survival and globe survival.

Naseripour M, Nazari H, Bakhtiari P, Modarres-zadeh M, Vosough P, Ausari M.

Br J Ophthalmol. 2009 Jan;93(1):28-32. doi: 10.1136/bjo.2008.139410. Epub 2008 Oct 24.

PMID:
18952647
14.

Familial retinoblastoma in developing countries.

Chantada GL, Dunkel IJ, Qaddoumi I, Antoneli CB, Totah A, Canturk S, Nawaiseh I, Fandiño A, Pífano I, Peksayar G, Ribeiro KB, Abramson DH.

Pediatr Blood Cancer. 2009 Sep;53(3):338-42. doi: 10.1002/pbc.21970.

PMID:
19434730
15.

Clinical presentation and outcome of retinoblastoma among children treated at the National Cancer Institute (NCI) in Gezira, Sudan: a single Institution experience.

Ali AA, Elsheikh SM, Elhaj A, Osman N, Abuidris D, Eltayeb EA, Mahgoub M, Hamdoun A, Babiker MM, Mohamedani AA, Elwali NE, Qaddoumi I.

Ophthalmic Genet. 2011 Jun;32(2):122-5. doi: 10.3109/13816810.2010.546822. Epub 2011 Mar 2.

PMID:
21366428
16.

Extensively necrotic retinoblastoma is associated with high-risk prognostic factors.

Chong EM, Coffee RE, Chintagumpala M, Hurwitz RL, Hurwitz MY, Chévez-Barrios P.

Arch Pathol Lab Med. 2006 Nov;130(11):1669-72.

PMID:
17076529
17.

Leiomyosarcoma of the maxilla as second malignancy in retinoblastoma.

Qureshi S, Mistry R, Natrajan G, Gujral S, Laskar S, Banavali S.

Indian J Cancer. 2008 Jul-Sep;45(3):123-5.

18.

Pre-enucleation chemotherapy for eyes severely affected by retinoblastoma masks risk of tumor extension and increases death from metastasis.

Zhao J, Dimaras H, Massey C, Xu X, Huang D, Li B, Chan HS, Gallie BL.

J Clin Oncol. 2011 Mar 1;29(7):845-51. doi: 10.1200/JCO.2010.32.5332. Epub 2011 Jan 31.

PMID:
21282531
19.

Metastatic retinoblastoma: single institution experience over two decades.

Cozza R, De Ioris MA, Ilari I, Devito R, Fidani P, De Sio L, Demelas F, Romanzo A, Donfrancesco A.

Br J Ophthalmol. 2009 Sep;93(9):1163-6. doi: 10.1136/bjo.2008.148932. Epub 2009 Jun 24.

PMID:
19556217
20.

Management of massive orbital involvement of intraocular retinoblastoma.

Kiratli H, Bilgiç S, Ozerdem U.

Ophthalmology. 1998 Feb;105(2):322-6.

PMID:
9479294

Supplemental Content

Support Center